Telomere and Telomerase as Targets for Cancer Therapy

被引：44
|
作者：
Tian, Xiaoping [1 ]
Chen, Bo [1 ]
Liu, Xiaochuan [1 ]
机构：
[1] Zhejiang Sci Tech Univ, Bioengn Inst, Life Sci Coll, Hangzhou 310018, Peoples R China
来源：
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY | 2010年 / 160卷 / 05期
关键词：
Telomere; Telomerase; Telomere dysfunction; Telomerase RNA; Cancer therapy; HTERT MESSENGER-RNA; REVERSE-TRANSCRIPTASE EXPRESSION; TUMOR-ASSOCIATED ANTIGEN; CYTOTOXIC T-LYMPHOCYTES; SINGLE-STRAND OVERHANG; GROWTH IN-VITRO; SUICIDE GENE; STEM-CELLS; CELLULAR SENESCENCE; INHIBITION;
D O I：
10.1007/s12010-009-8633-9
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Telomere maintenance and telomerase reactivation is essential for the transformation of most human cancer cells. Telomere shortening to the threshold length, mutations of the telomere-associated proteins, and/or telomerase RNA lead to telomeric dysfunction and therefore genomic instability. Telomerase up-regulation in 85% of human cancer cells has become a hallmark of cancers, hence a promising target for anticancer therapy. In this review, we discuss the mechanism of cancer due to telomere dysfunction and the resulting biological effects, the control of telomerase activity, and the new developments in cancer therapies targeting telomere and telomerase.
引用
收藏
页码：1460 / 1472
页数：13
相关论文
共 50 条
  • [31] Telomere and telomerase in oncology
    Jiao MU
    Li Xin WEI
    Cell Research, 2002, 12 : 1 - 7
  • [32] Telomeres and telomerase as therapeutic targets in the treatment of cancer
    Olaussen, Ken Andre
    Sabatier, Laure
    Besse, Benjamin
    Soria, Jean-Charles
    BULLETIN DU CANCER, 2006, 93 : 71 - 82
  • [33] Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof
    Claude, Eloise
    Decottignies, Anabelle
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2020, 60 : 1 - 8
  • [34] Targeting the limitless replicative potential of cancer: The telomerase/telomere pathway
    Kelland, Lloyd
    CLINICAL CANCER RESEARCH, 2007, 13 (17) : 4960 - 4963
  • [35] Clinical Relevance of Telomere Status and Telomerase Activity in Colorectal Cancer
    Fernandez-Marcelo, Tamara
    Sanchez-Pernaute, Andres
    Pascua, Irene
    De Juan, Carmen
    Head, Jacqueline
    Torres-Garcia, Antonio-Jose
    Iniesta, Pilar
    PLOS ONE, 2016, 11 (02):
  • [36] Telomere-related DNA damage response pathways in cancer therapy: prospective targets
    Gu, Liting
    Liu, Mingdi
    Zhang, Yuning
    Zhou, Honglan
    Wang, Yishu
    Xu, Zhi-Xiang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [37] Telomere Length and Telomerase Activity as Potential Biomarkers for Gastrointestinal Cancer
    Loukopoulou, Christina
    Nikolouzakis, Taxiarchis
    Koliarakis, Ioannis
    Vakonaki, Elena
    Tsiaoussis, John
    CANCERS, 2024, 16 (19)
  • [38] Current Progress in Targeting Telomere and Telomerase Enzymes for the Treatment of Cancer
    Garg, Aakriti
    Khan, Imran
    Nidhi
    Khan, Mohd. Ashif
    CURRENT CANCER THERAPY REVIEWS, 2024, 20 (01) : 26 - 39
  • [39] Clinical relevance of telomere length and telomerase activity in colorectal cancer
    De Juan Chocano, C.
    Fernandez-Marcelo, T.
    Pascua, I.
    Head, J.
    Sanchez-Pernaute, A.
    Torres, A. J.
    Benito, M.
    Iniesta, P.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S152 - S152
  • [40] Telomerase promotes formation of a telomere protective complex in cancer cells
    Perera, Omesha N.
    Sobinoff, Alexander P.
    Teber, Erdahl T.
    Harman, Ashley
    Maritz, Michelle F.
    Yang, Sile F.
    Pickett, Hilda A.
    Cesare, Anthony J.
    Arthur, Jonathan W.
    MacKenzie, Karen L.
    Bryan, Tracy M.
    SCIENCE ADVANCES, 2019, 5 (10):
12345